Media Type: Read
Stock Story: AMETEK
Alexander Whight, 04 Feb 2022
A high quality industrial company you may never have heard of AMETEK is a US listed, differentiated global industrial conglomerate.
How will corporates spend their excess cash and what does this mean for investors? Part II
Ian Robertson, 02 Feb 2022
Capital allocation is expected to continue to migrate towards capex, shareholder returns and M&A. Implications from this spend is case-by-case, but it is increasingly important for debt investors to know the capital allocation intentions of their investments and remain active in managing their portfolios to help position to benefit from some of these trends as well as avoid pitfalls of others.
8 tips to fast-track your savings in 2022
27 Jan 2022
ReadStock market volatility can be an opportunity for investors in the long term
Mark Riggall, 25 Jan 2022
Financial markets have started the year on a weak note, what’s behind the moves and how are we seeing things?
Interest
The new trend for Kiwi investors
18 Jan 2022
ReadStock Story: Neuren Pharmaceuticals
Kate Power, 12 Jan 2022
A promising new drug therapy for those with Rett Syndrome
In December, Neuren Pharmaceuticals and its partner Acadia Pharmaceuticals announced positive
Month in a Minute: December ’21
Mark Riggall, 12 Jan 2022
Portfolio Manager Mark Riggall discusses the month’s key highlights in 60 seconds.
A wider perspective
Fund returns in December were strong as
Corporate Demergers
Alexander Whight, 14 Dec 2021
Profiting from Management Spin? Opportunities presented by corporate demergers
Breaking up is hard to do. But that is the journey on
The Benefits of Diversification
Bruce O'Leary, 07 Dec 2021
ReadMonth in a Minute: November ’21
Mark Riggall, 06 Dec 2021
Portfolio Manager Mark Riggall discusses the month’s key highlights in 60 seconds.
Omicron the headline, interest rates remain the real story
November